Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.05. | IQ-AI Limited - Change of Name | 1 | RNS | ||
IMAGING BIOMETRICS Aktie jetzt für 0€ handeln | |||||
22.05. | IQ-AI Limited - Result of AGM | - | RNS | ||
02.05. | Imaging Biometrics seeks FDA breakthrough status for cancer therapy | 2 | Investing.com | ||
02.05. | Imaging Biometrics strebt FDA-Durchbruchstatus für Krebstherapie an | 3 | Investing.com Deutsch | ||
02.05. | IQ-AI Limited - Application: FDA Breakthrough Therapy Designation | 2 | RNS | ||
29.04. | IQ-AI Limited - Notice of AGM | - | RNS | ||
25.04. | IQ-AI Limited - Publication of Annual Report | - | RNS | ||
11.04. | IQ-AI reports early success in glioblastoma study | 1 | Investing.com | ||
11.04. | IQ-AI meldet frühe Erfolge in Glioblastom-Studie | 1 | Investing.com Deutsch | ||
11.04. | IQ-AI Limited - Promising Preliminary Results of Phase 1 Study | - | RNS | ||
18.03. | IQ-AI Limited - Placing to raise £250,000 | 3 | RNS | ||
18.03. | Braveheart Inv Group - Subscription in IQ-AI Limited Placing | - | RNS | ||
03.02. | IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis | 1 | Alliance News | ||
03.02. | IQ-AI Limited - IB Expands Distribution with Blackford | - | RNS | ||
22.01. | IQ-AI advances neuro-oncology AI, progresses glioblastoma trial | 1 | Investing.com | ||
22.01. | IQ-AI Limited - Operations Update | - | RNS | ||
10.01. | IQ-AI subsidiary and Prism partner for advanced neuroimaging | 1 | Investing.com | ||
10.01. | IQ-AI Limited - IB and Prism Secure First Installation | - | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GERRESHEIMER | 47,800 | -2,73 % | EQS-Adhoc: Gerresheimer AG: Anpassung der Prognose für 2025 | EQS-Ad-hoc: Gerresheimer AG / Schlagwort(e): Prognoseänderung/Dividende
Gerresheimer AG: Anpassung der Prognose für 2025
02.06.2025 / 11:40 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
MCKESSON | 626,60 | +0,16 % | Dividendenbekanntmachungen (02.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCOR SA FR0000120404 - 1,26 EUR ASSOCIATED BANC-CORP US0454871056 0,23 USD 0,2026 EUR ATOUR LIFESTYLE HOLDINGS LTD ADR US04965M1062 0... ► Artikel lesen | |
LIMES SCHLOSSKLINIKEN | 330,00 | 0,00 % | Limes Schlosskliniken will 2025 klar wachsen | 2024 kommt Limes Schlosskliniken wie im Vorjahr auf Gesamterträge von 38,0 Millionen Euro. Schon vor wenigen Wochen hatte Limes-Chef Gert Frank auf einer Konferenz von Oddo BHF in Frankfurt deutlich... ► Artikel lesen | |
BEYOND AIR | 0,158 | -1,86 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
HEALTHCARE SERVICES GROUP | 12,200 | -0,81 % | HCSG Reports Q4 2024 Results | BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended December 31, 2024.
Ted Wahl, Chief Executive Officer, stated, "2024... ► Artikel lesen | |
INTERPACE BIOSCIENCES | 0,650 | 0,00 % | Interpace Biosciences, Inc.: Effective May 2, 2025, Interpace Diagnostics Will No Longer Accept Specimens for PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk | Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, ("Interpace"... ► Artikel lesen | |
ADDUS HOMECARE | 96,50 | 0,00 % | Breaking Down Addus HomeCare: 6 Analysts Share Their Views | ||
MODERN DENTAL | 0,472 | +2,16 % | Dividendenbekanntmachungen (03.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEROPORTS DE PARIS SA FR0010340141 - 3 EUR ANHUI CONCH CEMENT CO LTD CNE1000001W2 0,7736 HKD 0,0862 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
ICU MEDICAL | 114,00 | -2,56 % | ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America | The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims... ► Artikel lesen | |
XYLO TECHNOLOGIES | 1,640 | 0,00 % | Xylo Technologies Ltd.: Viewbix Shares to Begin Trading on Nasdaq | TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced... ► Artikel lesen | |
ACADIA HEALTHCARE | 19,700 | 0,00 % | Pre-market Movers: Interactive Strength, DocGo, DLocal, Iovance Biotherapeutics, Acadia Healthcare | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.00 A.M. ET).In the Green Interactive Strength Inc. (TRNR) is up over 30% at... ► Artikel lesen | |
FRESH2 GROUP | 0,314 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 11.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.02.2025ISIN NameCA53635T1084 LIQUID... ► Artikel lesen | |
MEDIPAL | 13,700 | -0,72 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
THERACLION | 0,271 | 0,00 % | Theraclion Announces Financial Results 2024 and Reviews Progress | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,650 | +0,26 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |